E. Vanhecke

发表

Inhibition of tumor necrosis factor-induced phenotypes by short intracellular versions of latent membrane protein-1.

E. Adriaenssens, J. Coll, T. Ouk, 2010, Cellular signalling.

PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.

E. Brambilla, H. Popper, F. André, 2013, Lung cancer.

TrkA overexpression enhances growth and metastasis of breast cancer cells

R. Toillon, H. Hondermarck, B. Foveau, 2009, Oncogene.

Nerve growth factor is a potential therapeutic target in breast cancer.

H. Hondermarck, V. Nurcombe, E. Adriaenssens, 2008, Cancer research.

ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.

J. Pignon, E. Solary, L. Seymour, 2013, The New England journal of medicine.

The potential of exploiting DNA-repair defects for optimizing lung cancer treatment

A. Ashworth, J. Soria, C. Lord, 2012, Nature Reviews Clinical Oncology.

19q13-ERCC1 gene copy number increase in non--small-cell lung cancer.

I. Wistuba, P. Validire, F. André, 2013, Clinical lung cancer.

A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma

B. Al-Lazikani, D. Qian, H. Moch, 2011, Science Translational Medicine.

Target in Renal Cell Carcinoma A HIF-Regulated VHL-PTP 1 B-Src Signaling Axis Identifies a Therapeutic

B. Al-Lazikani, D. Qian, H. Moch, 2011 .

Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival

E. Germain, H. Hondermarck, V. Nurcombe, 2011, Clinical Cancer Research.

Breast Cancer Nerve Growth Factor Is a Potential Therapeutic Target in

H. Hondermarck, V. Nurcombe, E. Adriaenssens, 2008 .